Xuanzhu Biopharmaceutical (2575 HK)

Analysis

Industrials • China

Xuanzhu Biopharmaceutical is an innovation-driven biopharmaceutical company in China, specializing in the development, industrialization, and commercialization of small-molecule and macromolecular drugs. The company focuses on major therapeutic areas including digestive diseases, oncology, and non-alcoholic steatohepatitis (NASH), with key products like KBP-3571, XZP-3287, and XZP-3621. It is headquartered in Beijing, China, and was founded in 2002.

Refresh

Exchange Announcement • 17 Sep 2026 19:43

Voluntary Announcement Unusual Price Movements

Exchange Announcement • 16 Sep 2026 20:28

2025 Annual Report - Supplemental Information

Exchange Announcement • 16 Sep 2026 16:40

2026 Interim Report

Exchange Announcement • 03 Sep 2026 17:12

Voluntary Announcement Commercial Cooperation With Innobic For Bireociclib In The Thailand Market

Exchange Announcement • 26 Aug 2026 12:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Voluntary Announcement Unusual Price Movements

2025 Annual Report - Supplemental Information

2026 Interim Report

Voluntary Announcement Commercial Cooperation With Innobic For Bireociclib In The Thailand Market

Announcement Of Interim Results For The Six Months Ended June 30, 2026